AP
Antonio R Pera (Director) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in ANI Pharmaceuticals, Inc. (ANIP). The largest single filing was $692K of ANIP (7,292 sh × $94.94, as filed), executed Sep 3 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.2M
shares × price, as filed
Last traded
Sep 3 2025
Filed Sep 4 2025
Median ADV $26.1M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 24 months
Most traded names
ANIPRecent filings
ANIPSALE
ANI Pharmaceuticals, Inc.
View filing →
$692K7,292 sh × $94.94
Exec Sep 3 2025
Filed Sep 4 2025 · 5:30 PM ET ANIPSALE ANI Pharmaceuticals, Inc. View filing → $486K
5,421 sh × $89.73
Exec Aug 20 2025
Filed Aug 20 2025 · 5:30 PM ET